advertisement
Reply
 
Thread Tools Display Modes
Old 01-19-2022, 11:23 AM #41
Chemar's Avatar
Chemar Chemar is offline
Administrator
Community Support Team
 
Join Date: Aug 2006
Posts: 28,445
15 yr Member
Chemar Chemar is offline
Administrator
Community Support Team
Chemar's Avatar
 
Join Date: Aug 2006
Posts: 28,445
15 yr Member
Lightbulb Healthline MS INfo

A friend was asking for MS resources, and in addition to pointing her to this section, I also found a lot of helpful basic info on Healthline - so am sharing that link here as well.

Multiple Sclerosis Resource Center: Treatments, Managing Symptoms
Chemar is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
agate (01-19-2022)

advertisement
Old 06-03-2022, 02:55 PM #42
agate's Avatar
agate agate is offline
Senior Member
 
Join Date: Aug 2006
Location: Wild West
Posts: 1,007
15 yr Member
agate agate is offline
Senior Member
agate's Avatar
 
Join Date: Aug 2006
Location: Wild West
Posts: 1,007
15 yr Member
Arrow (MSAA) What's new in MS research (May 2022)

From the MSAA, "What's New in MS Research - May 2022":

What’s New in MS Research - May 2022 | MSAA

One of the articles may be noteworthy as it includes this:

Quote:
People receiving Ocrevus® (ocrelizumab) faced a 2.18 greater risk of developing COVID-19 post-vaccination relative to the general population, while those taking beta-interferon DMTs and glatiramer acetate (marketed as Copaxone® and by other names) had a lower risk than the general population. The post-vaccination risk of infection compared to that of the general population for people on other DMTs was:

Aubagio® (teriflunomide): 1.04
Mavenclad® (cladribine): 1.21
Tysabri (natalizumab): 1.22
Tecfidera® (dimethyl fumarate): 1.34
Gilenya® (fingolimod): 1.63

The investigators arrived at their findings by examining data on all 42,402 people in England who are receiving DMTs for treatment of MS. They found that more than 28,000 of those people had been tested for COVID-19, with 4,104 testing positive for coronavirus.
[Emphasis added]
__________________
Repeal the law of gravity!

MS diagnosed 1980. Type 2 diabetes, osteoarthritis.
Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, since 12/16/20
agate is offline   Reply With QuoteReply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Useful WebSites, Resources & Articles Bobbi Lyme Disease, Shingles and Other Microbial Conditions 8 05-20-2014 02:25 PM
Useful Websites and Resources for Anxiety & OCD Chemar Anxiety and OCD 11 05-02-2013 05:51 PM
Useful Websites & Resources Chemar Occipital Neuralgia and other Cranial Neuralgias 5 08-02-2012 02:16 PM
Useful Websites & Resources for PTSD Chemar Posttraumatic Stress Disorder 0 02-06-2008 06:30 PM


All times are GMT -5. The time now is 05:22 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.